MSH3 protein expression and nodal status in MLH1-deficient colorectal cancers.
Laghi L
Clin Cancer Res. 2012 Apr 10;18(11):3142-53. doi: 10.1158/1078-0432.CCR-12-0175
Microsatellite instability and therapeutic consequences in colorectal cancer.
Laghi L, Malesci A
Dig Dis. 2012 Jun 20;30(3):304-9. doi: 10.1159/000337003
Molecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasia.
Malesci A
Br J Cancer. 2014 Jan 16;110(5):1228-35. doi: 10.1038/bjc.2013.827
Multiple Roles for Chemokines in Neutrophil Biology.
Capucetti A, Albano F, Bonecchi R
Front Immunol. 2020 Jul 9;11:1259. doi: 10.3389/fimmu.2020.01259
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
Calura E
Clin Cancer Res. 2013 Jun 13;19(15):4114-23. doi: 10.1158/1078-0432.CCR-13-0360
Mode of action of trabectedin in myxoid liposarcomas.
Di Giandomenico S
Oncogene. 2013 Nov 11;33(44):5201-10. doi: 10.1038/onc.2013.462
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer.
Colombo N
Br J Cancer. 2019 Sep 20;121(9):744-750. doi: 10.1038/s41416-019-0584-5
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis.
Donadon M
J Exp Med. 217(11)doi: 10.1084/jem.20191847
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.
Brunetta E
Nat Immunol. 2020 Nov 18;22(1):19-24. doi: 10.1038/s41590-020-00832-x
Macrophage plasticity and polarization in tissue repair and remodelling.
Mantovani A
J Pathol. 2012 Nov 29;229(2):176-85. doi: 10.1002/path.4133